Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.

scientific article published on 19 August 2016

Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/NANO6080151
P932PMC publication ID5224619
P698PubMed publication ID28335280

P50authorRicardo Calderon-GonzalezQ53159765
José Gómez-RománQ56065788
Marco MarradiQ58204611
Isabel GarcíaQ60009601
Carmen Alvarez-DominguezQ64682880
Francisco Javier Freire VenegasQ77858385
Elisabet Frande-CabanesQ82049510
Sonsoles Yañez-DíazQ114431818
P2093author name stringSoledad Penadés
Héctor Terán-Navarro
Eva Ferrández-Fernández
P2860cites workSynthetic Nanoparticles for Vaccines and ImmunotherapyQ28085375
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.Q33493474
Dissociation of innate immune responses in microglia infected with Listeria monocytogenes.Q33797427
Immune reactions to Listeria monocytogenes in the brainQ33815015
Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8(+) T cells during pregnancyQ34455672
Two outbreaks of Listeria monocytogenes infection, Northern Spain.Q34641614
Listeriosis during pregnancy: a case series and review of 222 casesQ34778400
Perorally active nanomicellar formulation of quercetin in the treatment of lung cancerQ35753059
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccinesQ36200540
Molecular Epidemiology of Invasive Listeriosis due to Listeria monocytogenes in a Spanish Hospital over a Nine-Year Study Period, 2006-2014.Q36204032
Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.Q54335589
Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experienceQ57948785
Studies with Listeria monocytogenes lead the wayQ83241261
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccineQ95812278
Novel nanoparticle vaccines for ListeriosisQ36256378
Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material scienceQ36418242
Vaccine delivery using nanoparticles.Q36712817
Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasionQ37156803
Cutaneous listeriosisQ37470334
Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH.Q37595946
Listeriosis: a resurgent foodborne infectionQ37651089
Glyconanoparticles as multifunctional and multimodal carbohydrate systems.Q38071545
Nanovaccines and their mode of action.Q38102471
Applications of nanotechnology for immunologyQ38123937
In vitro and in vivo models to study human listeriosis: mind the gap.Q38154361
Nanoparticle vaccinesQ38167942
Nanoparticle based tailoring of adjuvant function: the role in vaccine developmentQ38493581
Alternatively activated microglia and macrophages in the central nervous system.Q38525488
Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines.Q41192471
Cheese-related listeriosis outbreak, Portugal, March 2009 to February 2012.Q41247861
A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infectionQ41497431
Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microgliaQ41956904
'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.Q41965469
Infection of pregnant mice with Listeria monocytogenes induces fetal bradycardiaQ46426910
TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in childrenQ46866845
Tubulin cofactor B plays a role in the neuronal growth cone.Q48312963
Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control studyQ48460256
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectlisteriosisQ160653
Listeria monocytogenesQ292015
nanoparticleQ61231
P577publication date2016-08-19
P1433published inNanomaterialsQ27724944
P1476titlePregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities
P478volume6

Reverse relations

cites work (P2860)
Q38680785Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.
Q37448708Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain.
Q40048669GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination.
Q39419658Glyco-gold nanoparticles: synthesis and applications
Q53159624Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.
Q92047320Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases
Q33578950Immunological properties of gold nanoparticles
Q92383586Public health impact of foodborne exposure to naturally occurring virulence-attenuated Listeria monocytogenes: inference from mouse and mathematical models
Q92539527Size and time-dependent induction of proinflammatory cytokines expression in brains of mice treated with gold nanoparticles
Q89907143Subcellular Performance of Nanoparticles in Cancer Therapy
Q48116102Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.

Search more.